How to Modernize Patient Narrative Writing
Lorem ipsum dolor sit amet consectetur. Donec diam risus volutpat tempor. Massa accumsan aliquam nibh…
Danielle Pillsbury2025 年 2 月 12 日
Certara’s Phoenix Platform – The world’s most trusted platform for PK/PD analysis and modeling
Today's drug candidates are more complex than ever. But with development decisions on the line,…
Danielle Pillsbury2025 年 2 月 12 日
Measuring metabolites in index clinical DDI studies
2025 年 2 月 7 日A key drug development safety consideration is whether the drug candidate will interact…
Danielle Pillsbury2025 年 2 月 7 日
Machine Learning for Population PK Model Selection: Theory and Practice
Three of Certara's expert modelers provide a gentle introduction to machine learning in our field.…
Danielle Pillsbury2025 年 2 月 7 日
Standards for All: Controlling Your Metadata for Vendors, Study Sites, and Submission Datasets
Director of Product, Certara's Pinnacle 21Senior Principal CDISC Consultant, Certara's Pinnacle 21Achieve submission ready conformance…
Danielle Pillsbury2025 年 2 月 7 日
Best Practices for International Pharma Content Roll-Out
2025 年 1 月 31 日 Pharmaceutical market access, sales, and field teams rely on high-quality, effective content…
Danielle Pillsbury2025 年 1 月 31 日
How to Validate Your Clinical Data Using FDA Validation Rules
2025 年 1 月 30 日 For clinical data managers, understanding clinical data validation and applying FDA validation…
Danielle Pillsbury2025 年 1 月 30 日
Phoenix Hosted: Cloud-Based PK/PD Software for Smarter, Faster Research
2025 年 5 月 13 日 - 美国东部时间上午 11:00
Danielle Pillsbury2025 年 1 月 30 日
Transforming Perspectives: 25 Years of PBPK Modeling in Drug-Drug Interactions
Vice President and Head of Global PK/PD and Pharmacometrics at Eli Lilly and Company Dr.…
Danielle Pillsbury2025 年 1 月 29 日
